Vol. 63 No. 1 (2017), ORIGINAL ARTICLES. A. PROTOCOLS OF CLINICAL RESEARCH

Vol. 63 No. 1 (2017)

COMPARATIVE FEATURES OF ENDOMETRIAL CANCER PATIENTS WITH A "STANDARD" AND "METABOLICALLY HEALTHY" OBESITY: GENETIC AND GENOTOXIC ASPECT

ORIGINAL ARTICLES. A. PROTOCOLS OF CLINICAL RESEARCH

https://doi.org/10.37469/0507-3758-2017-63-1-69-75

Published 01.01.2017

Lev Bershteyn⁺⁻
Aglaya Ievleva⁺⁻
Tatyana Poroshina⁺⁻
Irina Kovalenko⁺⁻

Lev Bershteyn

N.N. Petrov Research Institute of Oncology

Aglaya Ievleva

N.N. Petrov Research Institute of Oncology

Tatyana Poroshina

N.N. Petrov Research Institute of Oncology

Irina Kovalenko

N.N. Petrov Research Institute of Oncology

##article.numberofdownloads## 74

##article.numberofviews## 92

PDF (Русский)

Keywords

ENDOMETRIAL CANCER
DIFFERENTIATION
OBESITY
PHENOTYPES
GENOME
SYSTEMIC DNA DAMAGE
CLINICAL STAGE

How to Cite

Bershteyn, L., Ievleva, A., Poroshina, T., & Kovalenko, I. (2017). COMPARATIVE FEATURES OF ENDOMETRIAL CANCER PATIENTS WITH A "STANDARD" AND "METABOLICALLY HEALTHY" OBESITY: GENETIC AND GENOTOXIC ASPECT. Voprosy Onkologii, 63(1), 69–75. https://doi.org/10.37469/0507-3758-2017-63-1-69-75

Abstract

Background and Aims: Obesity is a known risk factor for endometrial cancer (EC), but connections of this tumor with different obesity phenotypes (namely ‘standard’, SO /characterized by insulin resistance / or ‘metabolically healthy’, MHO) were studied so far extremely rarely. The task of this study was to evaluate the role of genetic and genotoxic component in this issue.

Methods and Results: In 70-110 (depending on the method used) mainly postmenopausal EC patients was found that: a) The genotypes of leptin receptor (Gln223Arg) or FTO, fat mass and obesity associated (rs 9939609) genes are discovered in SO and MHO groups with different frequency; b) No differences exist between EC patients with SO or MHO in regard of such parameters like the tail moment and tail DNA% in comets of mononuclear cells, as well as in serum level of 8-hydroxy-2deoxyguanosine (8-OHdG) and in mononuclears’ telomeres length; c) In patients with EC combined with SO, TT genotype of the FTO gene correlates with a more advanced clinical stage of the disease, while comets characteristics - with a worse tumor differentiation; d) In EC patients with MHO, poorly differentiated carcinomas are combined more often with genotype AA of leptin receptor gene presence and with a trend to higher 8-OHdG blood level, while a more advanced clinical stage and (at the same time) a better tumor differentiation -with telomeres length.

Conclusions: The parameters that delineate a genome state and a degree of systemic DNA damage, can differ by their characteristics in EC patients with SO and MHO and not rarely are associated in various ways with clinical and morphological features of the tumor process in the two studied obesity phenotypes. Subsequently, there are grounds to study these issues taking into account the renovated classification of molecular biological types of endometrial cancer.

https://doi.org/10.37469/0507-3758-2017-63-1-69-75

##article.numberofdownloads## 74

##article.numberofviews## 92

PDF (Русский)

References

Берштейн Л.М. Гетерогенность ожирения и рак: потенциальная роль бурой жировой ткани // Вопр. он-кол. - 2012. - Т.58. - № 4. - С. 464-472.

Берштейн Л.М., Берлев И.В., Васильев Д.А. и др. Ожирение и особенности рака эндометрия: меняется ли что-нибудь с годами? // Вопр. онкол. - 2015. - Т.61. - № 4. - С. 575-579.

Методические рекомендации по определению физиологического резерва спортсмена на основе изучения теломеразной активности и длины теломер. М., 2013. - 33с. http://csp-athletics.ru/images/doc/metod/gen/metod-gen-04-02.pdf.

Соболева Н.П., Руднев С.Г., Николаев Д.В., Стерликов С.А. Биоимпедансный скрининг населения России в центрах здоровья: распространенность избыточной массы тела и ожирения // Российский мед. журнал. - 2014. - N 4. - С. 4-13.

Улыбина Ю.М., Имянитов Е.Н., Васильев Д.А., Берштейн Л.М. Полиморфные маркеры генов, определяющих нарушения жироуглеводного обмена и инсулинорезистентность, у онкологических больных // Мол. биология. - 2008. - Т. 42. - С. 947-956.

Al-Aubaidy HA, Jelinek HF. Oxidative DNA damage and obesity in type 2 diabetes mellitus // Eur J Endocrinol. - 2011. - Vol. 164(6). - P. 899-904.

Barrett JH, Iles MM, Dunning AM, Pooley KA. Telomere length and common disease: study design and analytical challenges // Hum Genet. - 2015. - Vol. 134(7). - P. 679-689.

Berezina A, Belyaeva O, Berkovich O et al. Prevalence, Risk Factors, and Genetic Traits in Metabolically Healthy and Unhealthy Obese Individuals // Biomed Res Int. - 2015. - 2015:548734.

Berstein L. Insulinemia, heterogeneity of obesity and the risk of different types of endometrial cancer: existing evidence // Expert Rev Endocrinol. Metabol. - 2016. - Vol. 11(1). - P. 51-64.

Berstein L. M. Renovated (nondual) approach to endometrial cancer typing: endocrine and inflammatory issues // Future Oncol. - 2017. - Vol. 13 (2). - P. 109-112.

Berstein L.M., Iyevleva A.G., Mukhina M.S. et al. Features of omental adipose tissue in endometrial cancer patients with ‘standard' or ‘metabolically healthy' obesity: associations with tumor process characteristics // SpringerPlus. - 2016. - Vol. 5: 1900. - P. 1-8.

Berstein L.M., Kvatchevskaya J.O., Poroshina T.E. et al. Insulin resistance, its consequences for the clinical course of the disease, and possibilities of correction in endometrial cancer // J Cancer Res Clin Oncol. - 2004. - Vol. 130(11). - P. 687-693.

Berstein L.M., Poroshina T.E., Turkevich E.A. et al. Features of endometrial cancer in patients with ‘metabolically healthy' versus ‘standard' obesity: The decreasing frequency of metabolically healthy obesity // Future Sci. Open Access. - 2015. - Vol. 1(4); DOI: 10.4155/fso.15.68

Brinton L.A., Trabert B., Anderson G.L. et al. Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women // Cancer Epidemiol Biomarkers Prev. - 2016. - Vol. 25(7). -P. 1081-1089.

Cawthon R.M. Telomere measurement by quantitative PCR // Nucleic Acids Res. - 2002. - Vol. 30(10). - e47.

Chaubey R.C. Computerized image analysis software for the comet assay // Methods Mol Biol. - 2005. - Vol. 291. - P. 97-106.

Duez P., Dehon G, Kumps A, Dubois J. Statistics of the Comet assay: a key to discriminate between genotoxic effects // Mutagenesis. - 2003. - Vol. 18(2). - P. 159-166.

Esposito K., Chiodini P., Capuano A. et al. Metabolic syndrome and endometrial cancer: a meta-analysis // Endocrine. - 2014. - Vol. 45 (1). - P. 28-36.

Kaaks R., Lukanova A., Kurzer M.S. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review // Cancer Epidemiol Biomarkers Prev. - 2002. - Vol. 11(12). - P. 1531-1543.

Karelis A.D., St-Pierre D.H., Conus F. et al. Metabolic and body composition factors in subgroups of obesity: what do we know? // J. Clin. Endocrinol. & Metabol. - 2004. - Vol. 89(6). - P. 2569-2575.

Kelly T, Yang W, Chen CS. et al. Global burden of obesity in 2005 and projections to 2030 // Int J Obes (Lond). -2008. - Vol. 32(9). - P. 1431-1437.

Lurie G., Gaudet M.M., Spurdle A.B., et al. The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white women // PLoS One. - 2011. - Vol. 6(2). - e16756.

Mathew H., Farr O.M., Mantzoros C.S. Understanding metabolically unhealthy normal weight or metabolically healthy obese patients // Metabolism. - 2016. - Vol. 65(1). - P73-80.

Matthews D.R., Hosker J.P., Rudenski A.S. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man // Diabetologia. - 1985. - Vol. 28(7). -P. 412-419.

McConechy M.K., Ding J., Cheang M.C. et al. Use of mutation profiles to refine the classification of endometrial carcinomas // J Pathol. - 2012. - Vol. 228(1). - P. 20-30.

Mundstock E., Sarria E.E., Zatti H. et al. Effect of obesity on telomere length: Systematic review and meta-analysis // Obesity (Silver Spring) - 2015. - Vol. 23(11). - P. 2165-2174.

Murali R, Soslow RA, Weigelt B. Classification of endometrial carcinoma: more than two types // Lancet Oncol. -2014. - Vol. 15(7). - e268-278.

Pigeyre M., Yazdi F.T., Kaur Y., Meyre D. Recent progress in genetics, epigenetics and metagenomics unveils the pathophysiology of human obesity // Clin Sci (Lond). - 2016. - Vol. 130(12). - P. 943-986.

Sheikh M.A., Althouse A.E., Freese K.E. et al. USA Endometrial Cancer Projections to 2030: should we be concerned? // Future Oncol. - 2014. - Vol. 10. - P. 2561 -2568.

Song F., Jia W., Yao Y. et al. Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed Type 2 diabetes // Clin Sci (Lond). - 2007. - Vol.112(12). - P. 599-606.

Tercjak M., Luczynski W., Wawrusiewicz-Kurylonek N., Bossowski A. The role of FTO gene polymorphism in the pathogenesis of obesity // Pediatr Endocrinol Diabetes Metab. - 2010. - Vol. 16(2). - P. 109-113.

Valavanidis A., Vlachogianni T., Fiotakis C. 8-hydroxy-2'-deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis // J Environ Sci Health (C Environ Carcinog Ecotoxicol Rev.) - 2009. - Vol. 27(2). - P. 120-139.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Yevgeniya Tsyrlina, Yelena Zhiltsova, Tatyana Poroshina, Irina Meshkova, Lev Bershteyn, Vladimir Semiglazov, N. Barash, OVARIAN CYSTS AND HYPERESTROGENIA AS A SIDE EFFECT OF TAMOXIFEN THERAPY IN BREAST CANCER PATIENTS OF REPRODUCTIVE AND POSTMENOPAUSAL AGE , Voprosy onkologii : Vol. 64 No. 1 (2018)
Tatyana Semiglazova, Yevgeniya Tsyrlina, Artem Poltoratskiy, Yekaterina Busko, Vladislav Semiglazov, Anna Artemeva, Sergey Ivanov, Lev Bershteyn, Vladimir Anisimov, Aleksey Belyaev, Vladimir Semiglazov, V. Kostorov, Aleksey Novik, Boris Kasparov, Mikhail Osipov, Petr Krivorotko, Veronika Klimenko, Garik Dashyan, Ruslan Paltuev, Yelena Zhiltsova, Tengiz Tabagua, Aleksandr Komyakhov, Kirill Nikolaev, Viktoriya Bashlyk, Roman Donskikh, V. Apollonova, MELATONIN AND METFORMIN IN NEOADJUVANT HORMONOTHERAPY IN LOCALLY ADVANCED BREAST CANCER , Voprosy onkologii : Vol. 64 No. 5 (2018)
Svetlana Aleksakhina, Aglaya Ievleva, Anna Sokolenko, Sofia Baskina, Ajgul Venina, Elena Anisimova, Nurmagomed Akhmedov, Alexandr Ivantsov, Yana Belysheva, Alexandra Chernyakova, Evgeny Imyanitov, Loss of heterozygosity in CHEK2-associated breast cancer , Voprosy onkologii : Vol. 67 No. 5 (2021)
Yevgeniy Imyanitov, Aleksey Belyaev, Aleksandr Shcherbakov, Lev Bershteyn, Aleksandr Bessonov, Petr Krivorotko, Tatyana Gorodnova, Khristina Kotiv, Igor Berlev, Anna Sokolenko, Vladimir Semiglazov, PRESENCE OF BRCA1 AND BRCA2 IN HEALTHY WOMEN AND MEN: DNA TESTING, DIAGNOSTIC ACTIVITIES AND CANCER PREVENTION , Voprosy onkologii : Vol. 63 No. 2 (2017)
Irina Kovalenko, Vladimir Semiglazov, Lev Bershteyn, Garik Dashyan, Tatyana Semiglazova, Roman Kamyshinskiy, Yevgeniya Tsyrlina, Tatyana Shtam, Roman Samsonov, Anastasiya Malek, EXOSOMAL MICRO-RNA - POTENTIAL PREDICTIVE MARKER OF BREAST CANCER NEOADJUVANT THERAPY EFFECT , Voprosy onkologii : Vol. 64 No. 6 (2018)
Marina Matsko, Dmitriy Matsko, Nikita Volkov, Aleksey Ulitin, Aglaya Ievleva, INFLUENCE OF CLINICAL CHARACTERISTICS AND VOLUME OF CYTOREDUCTION IN PATIENTS WITH PRIMARY GLIOBLASTOMA ON OVERALL SURVIVAL , Voprosy onkologii : Vol. 63 No. 6 (2017)
Lev Bershteyn, Tatyana Poroshina, Zamira Radzhabova, Irina Kovalenko, Aleksandr Ivantsov, Aglaya Ievleva, Igor Berlev, COMPARATIVE FEATURES OF CARBOHYDRATE METABOLISM STATE, BODY WEIGHT AND ASSOCIATED HORMONAL FACTORS IN VARIOUS MOLECULAR-BIOLOGICAL TYPES OF ENDOMETRIAL CANCER , Voprosy onkologii : Vol. 64 No. 3 (2018)
Fedor Moiseenko, Vladislav Tyurin, Nikita Levchenko, Yevgeniy Levchenko, Aglaya Ievleva, Yevgeniy Imyanitov, Natalya Mityushkina, DETECTION OF RESIDUAL LUNG CANCER CELLS BY PCR-BASED GENETIC TESTING FOR ROS1-TRANSLOCATION: CASE REPORT , Voprosy onkologii : Vol. 64 No. 3 (2018)
Lev Bershteyn, Aglaya Ievleva, Aleksandr Ivantsov, D. Vasiliev, Maksim Kleshchev, Tatyana Poroshina, Irina Kovalenko, A. Venina, I. Berlev, MODERN MOLECULAR BIOLOGICAL TYPES OF ENDOMETRIAL CANCER: COMPARATIVE ENDOCRINE AND PROINFLAMMATORY-PROGENOTOXIC CHARACTERISTICS , Voprosy onkologii : Vol. 65 No. 2 (2019)
Evgenia Vladimirovna, Tatyana Poroshina, Dmitry Vasilev , Diana Enalgieva, Piotr Krivorotko, Lev Bershtein, DNA Damage in Peripheral Blood Mononuclear Cells in Patients with Breast Cancer , Voprosy onkologii : Vol. 69 No. 4 (2023)

1 2 > >>